CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 02, 2021	Sep. 26, 2020
Cash flows from operating activities:
Consolidated Net Income	$ 738,980	$ 349,488
Adjustments to reconcile consolidated net income to net cash provided by operations:
Depreciation and amortization	146,924	140,654
Amortization of stock-based compensation	29,606	28,602
Equity in earnings of affiliated companies	(2,185)	(308)
Deferred income taxes	9,354	38,976
Impairments	4,482	7,223
Loss (gain) on investments, net	(10,820)	3,198
Other	3,190	4,043
Change in assets and liabilities, net of effects of acquired and disposed businesses:
Accounts receivable, net	(262,272)	533,570
Inventories	(581,766)	260,573
Accounts payable	136,329	(228,000)
Accrued expenses	174,583	29,154
Other assets and liabilities	4,685	(7,336)
Net cash provided by operating activities	391,090	1,159,837
Cash flows from investing activities:
Acquisition of property, plant, and equipment	(62,285)	(89,555)
Proceeds from sale of property, plant, and equipment	22,171	0
Other	373	(14,582)
Net cash used for investing activities	(39,741)	(104,137)
Cash flows from financing activities:
Change in short-term and other borrowings	(15,986)	(86,155)
Proceeds from (repayments of) long-term bank borrowings, net	289,235	(411,362)
Redemption of notes	(130,860)	(209,366)
Proceeds from exercise of stock options	44,938	5,963
Repurchases of common stock	(661,548)	(384,750)
Settlement of forward-starting interest rate swap	0	(48,378)
Other	(159)	(141)
Net cash used for financing activities	(474,380)	(1,134,189)
Effect of exchange rate changes on cash	(34,652)	5,405
Net decrease in cash and cash equivalents	(157,683)	(73,084)
Cash and cash equivalents at beginning of period	373,615	300,103
Cash and cash equivalents at end of period	$ 215,932	$ 227,019